BioSemi B.V.

BioSemi occupies a specialist position in research-grade electrophysiology hardware, serving laboratories that need high-channel-count acquisition across EEG, ECG, EMG, and auxiliary physiological signals. Its differentiation is technical rather than visible through scale or financing: active electrodes, low-power operation, 24-bit SAR conversion per channel, fully DC-coupled inputs, battery-powered front ends, and fiber-optic data transfer address signal quality, portability, synchronization, and electrical-noise constraints in demanding research settings. The ActiveThree platform supports up to 142 configurable EEG, EXG, and sensor channels, while the ActiveOne system supports as many as 144 channels. BioSemi also combines hardware with ActiView and LabVIEW-based programming for PC and Linux, giving researchers control over acquisition and analysis workflows. Its publication-oriented EEG positioning and broad sensor support distinguish it from narrower single-modality devices, but the company’s private status, limited disclosed financial information, and modest public operating footprint make market share and commercial scale difficult to quantify.

BioSemi’s trajectory reflects long-term, product-led development rather than a publicly documented venture-growth path. Founded in 1998 by Robert Honsbeek and colleagues with backgrounds in electronic engineering, physics, and medical-physics instrumentation, the company has expanded from academic research needs into a portfolio spanning amplifiers, active electrodes, auxiliary sensors, acquisition software, and high-channel-count systems. The product progression visible in the current profile suggests several technical inflection points: the ActiveTwo AD-Box supports up to 256 channels; the Active3 System introduces Mk3 connectors, optical fiber links, and triggered hyperscanning; and ActiveThree combines 128-channel architecture with up to 142 configurable EEG, EXG, and sensor channels. BioSemi’s technology also extends into automated auxiliary-sensor detection, battery-powered front ends, and Linux-compatible LabVIEW programming. There are no disclosed funding rounds, valuation events, hiring announcements, or dated expansion milestones to establish a faster recent growth rate. The company is categorized within the 51–100 employee range, although only one current featured position is identified, creating some uncertainty around workforce visibility. Overall, the evidence supports steady technical maturation and durable niche operations, not a quantified acceleration.